Similar articles

• FDA's new rule on treatment use and sale of investigational new drugs.

  Levine RJ. Levine RJ. IRB. 1987 Jul-Aug;9(4):1-4. IRB. 1987. PMID: 11649946 No abstract available.
• The paradoxical case of payment as benefit to research subjects.

  Macklin R. Macklin R. IRB. 1989 Nov-Dec;11(6):1-3. IRB. 1989. PMID: 11650284 No abstract available.
• Informed consent: the FDA's perspective.

  Bagley G. Bagley G. Food Drug Law J. 1993;48(2):181-6. Food Drug Law J. 1993. PMID: 11653141 No abstract available.
• Human experimentation. Protecting patient autonomy through informed consent.

  Tuthill KA. Tuthill KA. J Leg Med. 1997 Jun;18(2):221-50. doi: 10.1080/01947649709511033. J Leg Med. 1997. PMID: 9230568 Review. No abstract available.
• The standard of disclosure in human subject experimentation.

  Morin K. Morin K. J Leg Med. 1998 Jun;19(2):157-221. doi: 10.1080/01947649809511059. J Leg Med. 1998. PMID: 9658739 Review. No abstract available.